Evaluation of Nanodropper-mediated Microdrops vs Conventional Dropsof Proparacaine HCL 0.5 Percentage - Nil

anodropper, Inc.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1) Patients = 18 years
•2) Ability to provide informed consent for mode of topical anesthesia delivery
•3) Ability to verbally respond to pain
•4) Receiving treatment at AEH OPD (patient has undergone a preliminary examination and is awaiting dilation)

•1)Have a contraindication to local anaesthetics.
•2)Intravitreal injection within the past 14 days.
•3)Recent ocular surgery within the past 4 weeks.
•4)Preexisting diagnosis of ocular surface disease. requiring punctal plug placement.
•5)Evidence of any current ocular inflammation/infection.
•6)Any previous ocular condition (i.e., neurotrophic keratitis, herpetic eye disease, presence of a corneal graft, etc.) that has permanently altered the native sensation of the ocular surface.
•7)Use of contact lenses.
•8)Use of exclusionary medications:
•9)Topical steroid drops, NSAIDS, IOP lowering eye drops, any anti-viral medications used for herpes, Opioids

发起方

anodropper, Inc.